CN113456778A - Composition for improving energy and preparation method thereof - Google Patents
Composition for improving energy and preparation method thereof Download PDFInfo
- Publication number
- CN113456778A CN113456778A CN202110910351.6A CN202110910351A CN113456778A CN 113456778 A CN113456778 A CN 113456778A CN 202110910351 A CN202110910351 A CN 202110910351A CN 113456778 A CN113456778 A CN 113456778A
- Authority
- CN
- China
- Prior art keywords
- parts
- ginseng
- effects
- composition
- galangal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 63
- 238000002360 preparation method Methods 0.000 title abstract description 13
- 235000008434 ginseng Nutrition 0.000 claims abstract description 41
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 40
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 40
- 235000007215 black sesame Nutrition 0.000 claims abstract description 29
- 244000062241 Kaempferia galanga Species 0.000 claims abstract description 28
- 235000013421 Kaempferia galanga Nutrition 0.000 claims abstract description 28
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 27
- 240000000950 Hippophae rhamnoides Species 0.000 claims abstract description 22
- 238000002156 mixing Methods 0.000 claims abstract description 22
- 241000382455 Angelica sinensis Species 0.000 claims abstract description 21
- 241000005787 Cistanche Species 0.000 claims abstract description 17
- 241000222336 Ganoderma Species 0.000 claims abstract description 17
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 17
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 14
- 239000008158 vegetable oil Substances 0.000 claims abstract description 14
- 238000010438 heat treatment Methods 0.000 claims abstract description 4
- 241000208340 Araliaceae Species 0.000 claims description 40
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 18
- 241000209020 Cornus Species 0.000 claims description 17
- 244000197580 Poria cocos Species 0.000 claims description 16
- 238000012545 processing Methods 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 11
- 241000229143 Hippophae Species 0.000 claims description 10
- 240000008397 Ganoderma lucidum Species 0.000 claims description 9
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 9
- 239000000796 flavoring agent Substances 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 244000141331 Amomum villosum Species 0.000 claims description 7
- 235000012907 honey Nutrition 0.000 claims description 7
- 241000125175 Angelica Species 0.000 claims description 6
- 235000013355 food flavoring agent Nutrition 0.000 claims description 6
- 230000001965 increasing effect Effects 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 59
- 210000003734 kidney Anatomy 0.000 abstract description 39
- 210000004369 blood Anatomy 0.000 abstract description 32
- 239000008280 blood Substances 0.000 abstract description 32
- 239000003814 drug Substances 0.000 abstract description 18
- 230000006870 function Effects 0.000 abstract description 18
- 210000000952 spleen Anatomy 0.000 abstract description 17
- 210000004185 liver Anatomy 0.000 abstract description 15
- 230000001737 promoting effect Effects 0.000 abstract description 14
- 210000002216 heart Anatomy 0.000 abstract description 10
- 230000002633 protecting effect Effects 0.000 abstract description 9
- 239000003921 oil Substances 0.000 abstract description 8
- 235000019198 oils Nutrition 0.000 abstract description 8
- 229940079593 drug Drugs 0.000 abstract description 7
- 230000036039 immunity Effects 0.000 abstract description 7
- 208000002193 Pain Diseases 0.000 abstract description 6
- 150000001413 amino acids Chemical class 0.000 abstract description 6
- 230000001105 regulatory effect Effects 0.000 abstract description 6
- 230000003647 oxidation Effects 0.000 abstract description 5
- 238000007254 oxidation reaction Methods 0.000 abstract description 5
- 238000005728 strengthening Methods 0.000 abstract description 5
- 229930003231 vitamin Natural products 0.000 abstract description 5
- 235000013343 vitamin Nutrition 0.000 abstract description 5
- 239000011782 vitamin Substances 0.000 abstract description 5
- 229940088594 vitamin Drugs 0.000 abstract description 5
- 235000001188 Peltandra virginica Nutrition 0.000 abstract description 4
- 239000012530 fluid Substances 0.000 abstract description 4
- 210000000936 intestine Anatomy 0.000 abstract description 4
- 230000003908 liver function Effects 0.000 abstract description 4
- 238000010792 warming Methods 0.000 abstract description 4
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 230000001914 calming effect Effects 0.000 abstract description 3
- 238000003304 gavage Methods 0.000 abstract description 3
- 241000411851 herbal medicine Species 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 230000005906 menstruation Effects 0.000 abstract description 3
- 241000721047 Danaus plexippus Species 0.000 abstract description 2
- 230000004087 circulation Effects 0.000 abstract description 2
- 230000000857 drug effect Effects 0.000 abstract description 2
- 210000005036 nerve Anatomy 0.000 abstract description 2
- 235000015097 nutrients Nutrition 0.000 abstract description 2
- 238000010298 pulverizing process Methods 0.000 abstract description 2
- 230000008093 supporting effect Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 description 23
- 239000000047 product Substances 0.000 description 19
- 230000002401 inhibitory effect Effects 0.000 description 14
- 244000061520 Angelica archangelica Species 0.000 description 12
- 241000699666 Mus <mouse, genus> Species 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 10
- 239000000284 extract Substances 0.000 description 10
- 230000009471 action Effects 0.000 description 9
- 230000000144 pharmacologic effect Effects 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 7
- 229930182494 ginsenoside Natural products 0.000 description 7
- 230000001603 reducing effect Effects 0.000 description 7
- 235000019640 taste Nutrition 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 206010003549 asthenia Diseases 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 229940089161 ginsenoside Drugs 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 239000000341 volatile oil Substances 0.000 description 6
- 235000003935 Hippophae Nutrition 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 230000000202 analgesic effect Effects 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- IQVQXVFMNOFTMU-FLIBITNWSA-N (Z)-ligustilide Chemical compound C1CC=CC2=C1C(=C/CCC)/OC2=O IQVQXVFMNOFTMU-FLIBITNWSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 241000759833 Cornus officinalis Species 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 208000031975 Yang Deficiency Diseases 0.000 description 4
- IQVQXVFMNOFTMU-DHZHZOJOSA-N Z-ligustilide Natural products C1CC=CC2=C1C(=C/CCC)\OC2=O IQVQXVFMNOFTMU-DHZHZOJOSA-N 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 210000003169 central nervous system Anatomy 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 210000000582 semen Anatomy 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 230000002110 toxicologic effect Effects 0.000 description 4
- 231100000759 toxicological effect Toxicity 0.000 description 4
- 230000002936 tranquilizing effect Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000010228 Erectile Dysfunction Diseases 0.000 description 3
- 229920002527 Glycogen Polymers 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 210000000748 cardiovascular system Anatomy 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000012259 ether extract Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229940096919 glycogen Drugs 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 239000007928 intraperitoneal injection Substances 0.000 description 3
- 238000010253 intravenous injection Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 210000004291 uterus Anatomy 0.000 description 3
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 2
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 2
- 241001127714 Amomum Species 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- YTZSBJLNMIQROD-SFBCHFHNSA-N Morroniside Chemical compound O([C@@H]1OC=C([C@H]2C[C@H](O)O[C@@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YTZSBJLNMIQROD-SFBCHFHNSA-N 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- 241000222341 Polyporaceae Species 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 235000003434 Sesamum indicum Nutrition 0.000 description 2
- 244000000231 Sesamum indicum Species 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- HLXRWTJXGMHOFN-XJSNKYLASA-N Verbenalin Chemical compound O([C@@H]1OC=C([C@H]2C(=O)C[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HLXRWTJXGMHOFN-XJSNKYLASA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 241000234299 Zingiberaceae Species 0.000 description 2
- KGEKLUUHTZCSIP-HOSYDEDBSA-N [(1s,4s,6r)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl] acetate Chemical compound C1C[C@]2(C)[C@H](OC(=O)C)C[C@H]1C2(C)C KGEKLUUHTZCSIP-HOSYDEDBSA-N 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 2
- 239000009188 angelicae sinensis extract Substances 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 230000000767 anti-ulcer Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 206010013023 diphtheria Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 2
- -1 etc. Natural products 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 230000002964 excitative effect Effects 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- VCCRNZQBSJXYJD-UHFFFAOYSA-N galangin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=CC=C1 VCCRNZQBSJXYJD-UHFFFAOYSA-N 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000003394 haemopoietic effect Effects 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- SQFSKOYWJBQGKQ-UHFFFAOYSA-N kaempferide Chemical compound C1=CC(OC)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 SQFSKOYWJBQGKQ-UHFFFAOYSA-N 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 210000000944 nerve tissue Anatomy 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000019633 pungent taste Nutrition 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000010254 subcutaneous injection Methods 0.000 description 2
- 239000007929 subcutaneous injection Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 229940096998 ursolic acid Drugs 0.000 description 2
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- GRWFGVWFFZKLTI-UHFFFAOYSA-N α-pinene Chemical compound CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 2
- FQTLCLSUCSAZDY-UHFFFAOYSA-N (+) E(S) nerolidol Natural products CC(C)=CCCC(C)=CCCC(C)(O)C=C FQTLCLSUCSAZDY-UHFFFAOYSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- LAOVEVDFIVNYLQ-QDQSDLQTSA-N (2s,3r,4s,5r,6r)-2-[[(2r,3r,4s,5r,6s)-6-[[(2r,3s,4s,5s)-3,4-dihydroxy-5-(hydroxymethyl)-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methoxy]-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H]2[C@H]([C@H](O)[C@](CO)(O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)O2)O)O1 LAOVEVDFIVNYLQ-QDQSDLQTSA-N 0.000 description 1
- YTZSBJLNMIQROD-UHFFFAOYSA-N (4aS)-1c-beta-D-glucopyranosyloxy-6xi-hydroxy-8t-methyl-(4ar,8ac)-5,6,8,8a-tetrahydro-1H,4aH-pyrano[3,4-c]pyran-4-carboxylic acid methyl ester Natural products C12C(C)OC(O)CC2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O YTZSBJLNMIQROD-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- OKMWKBLSFKFYGZ-UHFFFAOYSA-N 1-behenoylglycerol Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO OKMWKBLSFKFYGZ-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- GRWFGVWFFZKLTI-IUCAKERBSA-N 1S,5S-(-)-alpha-Pinene Natural products CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 1
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- KMTDMTZBNYGUNX-UHFFFAOYSA-N 4-methylbenzyl alcohol Chemical compound CC1=CC=C(CO)C=C1 KMTDMTZBNYGUNX-UHFFFAOYSA-N 0.000 description 1
- HVDFMKSCPKILEQ-UHFFFAOYSA-N 5-methoxy-2,3-dimethylphenol Chemical compound COC1=CC(C)=C(C)C(O)=C1 HVDFMKSCPKILEQ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- UCTWMZQNUQWSLP-UHFFFAOYSA-N Adrenaline Natural products CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 1
- 241000013298 Alpinia <beetle> Species 0.000 description 1
- 244000141218 Alpinia officinarum Species 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- RMMXTBMQSGEXHJ-UHFFFAOYSA-N Aminophenazone Chemical compound O=C1C(N(C)C)=C(C)N(C)N1C1=CC=CC=C1 RMMXTBMQSGEXHJ-UHFFFAOYSA-N 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 241001571352 Amomum longiligulare Species 0.000 description 1
- 206010002482 Angiosclerosis Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 241000336291 Cistanche deserticola Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241001117772 Elaeagnaceae Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- UIOFUWFRIANQPC-JKIFEVAISA-N Floxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl UIOFUWFRIANQPC-JKIFEVAISA-N 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 241001489091 Ganoderma sinense Species 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 1
- 235000021353 Lignoceric acid Nutrition 0.000 description 1
- CQXMAMUUWHYSIY-UHFFFAOYSA-N Lignoceric acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 CQXMAMUUWHYSIY-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- AMBQHHVBBHTQBF-UHFFFAOYSA-N Loganin Natural products C12C(C)C(O)CC2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O AMBQHHVBBHTQBF-UHFFFAOYSA-N 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- FQTLCLSUCSAZDY-ATGUSINASA-N Nerolidol Chemical compound CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C FQTLCLSUCSAZDY-ATGUSINASA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000308150 Orobanchaceae Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000002791 Panax Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 241000207960 Pedaliaceae Species 0.000 description 1
- 241000228150 Penicillium chrysogenum Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241001127637 Plantago Species 0.000 description 1
- 206010051986 Pneumatosis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- 208000022329 Protein metabolism disease Diseases 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- LUSZGTFNYDARNI-UHFFFAOYSA-N Sesamol Natural products OC1=CC=C2OCOC2=C1 LUSZGTFNYDARNI-UHFFFAOYSA-N 0.000 description 1
- ZZMNWJVJUKMZJY-UHFFFAOYSA-N Sesamolin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-UHFFFAOYSA-N 0.000 description 1
- ZZMNWJVJUKMZJY-AFHBHXEDSA-N Sesamolin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-AFHBHXEDSA-N 0.000 description 1
- LAOVEVDFIVNYLQ-OMMQBQFASA-N Sesamose Natural products O(C[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H]2[C@H](O)[C@@H](O)[C@@](O[C@@H]3[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O3)(CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 LAOVEVDFIVNYLQ-OMMQBQFASA-N 0.000 description 1
- 235000009367 Sesamum alatum Nutrition 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- HEYZWPRKKUGDCR-QBXMEVCASA-N Swertiamarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](C=C)[C@]2(O)CCOC(=O)C2=CO1 HEYZWPRKKUGDCR-QBXMEVCASA-N 0.000 description 1
- HEYZWPRKKUGDCR-WRMJXEAJSA-N Swertiamarin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@H]1[C@@H](C=C)[C@@]2(O)C(C(=O)OCC2)=CO1 HEYZWPRKKUGDCR-WRMJXEAJSA-N 0.000 description 1
- 241001540751 Talaromyces ruber Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241001480050 Trichophyton violaceum Species 0.000 description 1
- 241000009298 Trigla lyra Species 0.000 description 1
- HLXRWTJXGMHOFN-UHFFFAOYSA-N Verbenalin Natural products C12C(C)CC(=O)C2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O HLXRWTJXGMHOFN-UHFFFAOYSA-N 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 229940102884 adrenalin Drugs 0.000 description 1
- 230000001800 adrenalinergic effect Effects 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- XUEHVOLRMXNRKQ-KHMAMNHCSA-N alpha cubebene Natural products CC(C)[C@@H]([C@H]12)CC[C@@H](C)[C@]32[C@@H]1C(C)=CC3 XUEHVOLRMXNRKQ-KHMAMNHCSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 229960000212 aminophenazone Drugs 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000000703 anti-shock Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 229940115397 bornyl acetate Drugs 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- QXDMQSPYEZFLGF-UHFFFAOYSA-L calcium oxalate Chemical compound [Ca+2].[O-]C(=O)C([O-])=O QXDMQSPYEZFLGF-UHFFFAOYSA-L 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- CCRCUPLGCSFEDV-UHFFFAOYSA-N cinnamic acid methyl ester Natural products COC(=O)C=CC1=CC=CC=C1 CCRCUPLGCSFEDV-UHFFFAOYSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- XUEHVOLRMXNRKQ-HKGGGCDWSA-N cubebene Chemical compound CC(C)[C@H]([C@@H]12)CC[C@H](C)C32C1C(C)=CC3 XUEHVOLRMXNRKQ-HKGGGCDWSA-N 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- CIPSYTVGZURWPT-UHFFFAOYSA-N galangin Natural products OC1=C(Oc2cc(O)c(O)cc2C1=O)c3ccccc3 CIPSYTVGZURWPT-UHFFFAOYSA-N 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 229940107131 ginseng root Drugs 0.000 description 1
- 229940049654 glyceryl behenate Drugs 0.000 description 1
- 230000002710 gonadal effect Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 230000000055 hyoplipidemic effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 1
- 235000008800 isorhamnetin Nutrition 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- AMBQHHVBBHTQBF-UOUCRYGSSA-N loganin Chemical compound O([C@@H]1OC=C([C@H]2C[C@H](O)[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O AMBQHHVBBHTQBF-UOUCRYGSSA-N 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000008897 memory decline Effects 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- CCRCUPLGCSFEDV-BQYQJAHWSA-N methyl trans-cinnamate Chemical compound COC(=O)\C=C\C1=CC=CC=C1 CCRCUPLGCSFEDV-BQYQJAHWSA-N 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- WASNIKZYIWZQIP-AWEZNQCLSA-N nerolidol Natural products CC(=CCCC(=CCC[C@@H](O)C=C)C)C WASNIKZYIWZQIP-AWEZNQCLSA-N 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- SUYJZKRQHBQNCA-UHFFFAOYSA-N pinobanksin Natural products O1C2=CC(O)=CC(O)=C2C(=O)C(O)C1C1=CC=CC=C1 SUYJZKRQHBQNCA-UHFFFAOYSA-N 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000028527 righting reflex Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- NCTHNHPAQAVBEB-WGCWOXMQSA-M sodium ferulate Chemical compound [Na+].COC1=CC(\C=C\C([O-])=O)=CC=C1O NCTHNHPAQAVBEB-WGCWOXMQSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- QZZGJDVWLFXDLK-UHFFFAOYSA-N tetracosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCC(O)=O QZZGJDVWLFXDLK-UHFFFAOYSA-N 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention belongs to the technical field of Chinese herbal medicines, and discloses a composition for improving energy and a preparation method thereof. The composition takes the cistanche as a monarch drug, and has the effects of tonifying kidney and supporting yang, and moistening intestines and promoting fluid production; the lucid ganoderma has the effects of tonifying qi, soothing the nerves, purifying blood and protecting liver function; corni fructus has effects of tonifying liver and kidney, astringing, and strengthening body constitution; angelica sinensis has the effects of enriching blood, regulating menstruation, protecting kidney and resisting oxidation; the ginseng is a ministerial drug which has the effects of warming the nature and entering the liver channel, tonifying the kidney and strengthening yang, enriching the blood and lifting qi; the sea-buckthorn is used for improving the immunity; fructus Amomi warms the middle-jiao and promotes qi circulation; galangal can dispel cold and relieve pain, and the whole formula is introduced; the tuckahoe and the black sesame have the functions of strengthening spleen and calming heart, tonifying essence and blood, being rich in a large amount of amino acids and various vitamins and promoting the absorption capacity of nutrient components. The preparation method comprises mixing vegetable oil with Chinese medicinal materials at short-time heating temperature, pulverizing all the materialsThen the mixture is blended into the oil solution again, the drug effect of the finished product is ensured, no toxic or side effect is caused, and the finished product meets the condition that the content of the effective components is lower than that of mouse gavage LD50And (4) standard amount.
Description
Technical Field
The invention belongs to the technical field of Chinese herbal medicines, and particularly relates to a composition for improving energy and a preparation method thereof.
Background
Modern people need to be energetic at any time to solve a plurality of things in work and life due to high working pressure and high living pressure. However, as the rhythm accelerates, various problems occur in the human body.
The most common phenomenon in the existing life is energy reduction caused by kidney deficiency. Kidney deficiency refers to the deficiency of kidney essence, qi, yin and yang. There are many kinds of kidney deficiency, and the most common of them is kidney yin deficiency and kidney yang deficiency. Symptoms of kidney deficiency: the symptoms of kidney-yang deficiency include soreness of waist, cold limbs, intolerance of cold, even edema, cold symptoms, and poor sexual function which can also cause kidney-yang deficiency; the symptom of kidney yin deficiency is "heat", and mainly includes soreness of waist, dryness-heat, night sweat, sweating due to debility, dizziness, tinnitus, etc. Modern science proves that when people suffer from kidney deficiency, the immunity of people is reduced no matter the kidney is yin deficient or the kidney is yang deficient, and more evidence shows that when the kidney deficiency occurs, the immunity of the kidney is reduced, the microcirculation system of the kidney is also blocked, and the kidney collaterals are blocked. Therefore, the treatment of kidney deficiency should be combined with prevention and treatment.
The symptoms of kidney deficiency manifest themselves mentally as: memory decline, hypomnesis, inattention, lack of energy, and reduced work efficiency. The symptoms of kidney deficiency are emotionally manifested as: poor mood is often difficult to control, dizziness, irritability, anxiety, depression, and the like. Symptoms of kidney deficiency are expressed in the mind: lack of confidence, no enthusiasm for work, no enthusiasm for life, no goal and no direction.
At present, a lot of medicines or health care products for tonifying the kidney and improving energy are available on the market, but the effect of most medicines is not good, the side effect of most medicines is more, the harm to the health of human bodies can be caused, and the health care products have certain effect, but the health care products are high in price and are not enough in absorption rate for users.
Disclosure of Invention
In order to solve the above problems in the prior art, the present invention aims to provide a composition for increasing energy and a preparation method thereof.
The technical scheme adopted by the invention is as follows: the composition for improving energy is mainly prepared from the following raw materials in parts by mass:
10-15 parts of cistanche, 6-12 parts of lucid ganoderma, 5-10 parts of dogwood, 6-12 parts of angelica sinensis, 3-10 parts of ginseng, 3-9 parts of sea buckthorn, 3-6 parts of fructus amomi, 3-6 parts of galangal, 10-15 parts of poria cocos and 9-15 parts of black sesame.
Cistanche deserticola, name of traditional Chinese medicine. Is fleshy stem with scaly leaf of Cistanchis herba Y.C.Ma of Cistanche of Orobanchaceae. Has the effects of tonifying kidney, supporting yang, moistening intestine and relaxing bowels. Can be used for treating kidney yang deficiency, essence and blood deficiency, sexual impotence, premature ejaculation, infertility due to cold womb, soreness of waist and knees, asthenia, intestinal dryness, and constipation. Sweet, salty and warm in nature; it enters kidney and large intestine meridians.
Ganoderma lucidum and Chinese medicine name. Is dried fruiting body of Ganoderma lucidum (Leys. ex Fr.) Karst or Ganoderma sinense Zhao, Xu et Zhang of Ganoderma of Polyporaceae. Has effects of invigorating qi, tranquilizing mind, relieving cough and asthma. It can be used for treating restlessness of heart-mind, insomnia, palpitation due to fright, cough, asthma, excessive phlegm, and asthenia. Sweet in taste and neutral in nature; it enters heart, lung, liver and kidney meridians. The chemical composition contains polysaccharide, nucleoside, furan, sterol, alkaloid, triterpenes, oil, amino acids, proteins, enzymes, organic germanium, trace elements, etc. The pharmacological action of the ganoderma lucidum polysaccharide has the functions of regulating immunity, reducing blood sugar, reducing blood fat, resisting oxidation, resisting aging and resisting tumors; the triterpenes can purify blood and protect liver function; the Ganoderma preparation has tranquilizing, anticonvulsive, heart tonifying, arrhythmia relieving, blood pressure lowering, cough relieving, and asthma relieving effects; in addition, Ganoderma has anticoagulant, platelet aggregation inhibiting and antiallergic effects. Ganoderma lucidum has less toxicity due to toxicity, and Ganoderma lucidum percolate LD is injected into abdominal cavity of mouse5038.3 + -1.04 g/kg, and is prepared by intraperitoneal injection of hot alcohol extract of Ganoderma lucidum, and mouse LD506.75g/kg, the intragastric MLD is 165g/kg, the toxicity of the cold alcohol extract is lower, the rats are intragastric for 1.2g/kg and 12g/kg every day for 30 days, and the toxicity on growth and development, liver function, electrocardiogram and the like is avoided.
Cornus officinalis, the name of traditional Chinese medicine. Is dried mature pulp of Cornus officinalis Sieb.et Zucc. Has effects of invigorating liver and kidney, astringing and inducing astringency. Can be used for treating soreness of waist and knees, dizziness, tinnitus, sexual impotence, spermatorrhea, enuresis, frequent micturition, metrorrhagia, menorrhagia, profuse sweating, and asthenia. Sour and astringent taste, slightly warm nature; it enters liver and kidney meridians. Chemical components: the fruit contains cornin, ursolic acid, morroniside, 7-0-methyl morroniside, swertiamarin, and loganin. In addition, gallic acid, malic acid, tartaric acid, provitamin A, saponin, tannin, etc. can be added. The pharmacological action is as follows: 1. the function of resisting pathogenic microorganisms: the Corni fructus decoction can inhibit growth of Staphylococcus aureus in vitro, sour liquid obtained from fresh fruit pulp has inhibitory effect on typhoid fever and dysentery bacteria, and water infusion has inhibitory effect on Trichophyton violaceum in test tube to different degrees. 2. Impact on the immune system: the dogwood with different dosages can obviously increase the content of IgG in the serum of mice. And shows a significant inhibitory effect on contact dermatitis caused by DNCB. 3. Effects on substance metabolism: corni fructus has obvious effect in resisting adrenergic hyperglycemia, and can increase liver glycogen. Ursolic acid separated from fructus Corni ether extract can significantly reduce blood sugar and urine sugar. 4. Effects on the cardiovascular system: animal experiments prove that the dogwood can cause the blood pressure of shock animals to rise and the amplitude of heart beat waves to be increased, and has the antishock effect. 5. Effects on the blood system: the dogwood can reduce the specific viscosity of whole blood of a rat with hyperglycemia. And can inhibit platelet aggregation. 6. In addition, cornus officinalis has certain diuretic, anti-inflammatory, anticancer, antioxidant and anti-aging effects. And (3) toxicological effects: has low toxicity and can cause mild hyperemia on rabbit gastric mucosa.
Chinese angelica root, named as Chinese medicine. Is root of Angelica sinensis (Oliv) Diels. of Angelica of Umbelliferae. Has effects of replenishing blood, regulating menstruation, promoting blood circulation, relieving pain, and loosening bowel to relieve constipation. It can be used for treating blood deficiency, sallow complexion, menoxenia, amenorrhea, dysmenorrhea, blood deficiency, blood stagnation, pain due to blood cold, traumatic injury, rheumatalgia, superficial infection, pyocutaneous disease, intestinal dryness, and constipation. Sweet and pungent in flavor and warm in nature; it enters liver, heart and spleen meridians. Chemical components: the angelica contains neutral compounds such as beta-pinene, alpha-pinene, camphene and the likeAn oil component. Contains acidic oil components such as p-methylbenzyl alcohol and 5-methoxy-2, 3-xylenol, organic acid, saccharide, vitamins, amino acids, etc. The pharmacological action is as follows: 1. effects on the reproductive system: angelica sinensis has the function of regulating uterine smooth muscle in two directions. Mainly plays a role in inhibiting the isolated uterus and has a role in stimulating the in vivo uterus. 2. Effects on the cardiovascular system: the radix Angelicae sinensis fluid extract has effect in resisting myocardial ischemia, and radix Angelicae sinensis neutral oil also has protective effect on myocardial ischemia. It also has antiarrhythmic effect. The radix Angelicae sinensis extract has effects of dilating coronary artery and increasing coronary blood flow. 3. Effects on the blood system: the radix Angelicae sinensis powder has effects of reducing blood lipid and protecting arteriosclerosis aorta pathological changes. Ligustilide in radix Angelicae sinensis extract has platelet aggregation inhibiting effect. The angelica and the ferulic acid thereof have obvious antithrombotic effect. Angelica polysaccharide has the function of promoting hematopoiesis. 4. Impact on the immune system: the total acid of radix Angelicae sinensis has effects of improving cellular immunity and promoting humoral immunity. Angelica polysaccharide also has immunity enhancing effect. 5. Effects on the central nervous system: the effective component ligustilide in angelica has the function of inhibiting the central nervous system, and angelica has the analgesic function which is stronger than aminopyrine, the acute toxicity is extremely low 6, and the function of resisting pathogenic microorganisms is as follows: the angelica has antibacterial effects on in vitro dysentery, typhoid, paratyphoid, escherichia coli, diphtheria bacillus, vibrio cholerae, alpha and beta hemolytic streptococcus and the like; 7. impact on the respiratory system: the radix Angelicae sinensis component ligustilide has antiasthmatic effect. 8. In addition, radix Angelicae sinensis has effects of protecting liver, resisting tumor, resisting radiation, resisting inflammation, protecting kidney, resisting oxidation, and correcting protein metabolism disorder. And (3) toxicological effects: the toxicity of angelica is low, and LD of angelica is injected into mice by vein5080-100 g/kg; subcutaneous injection and intragastric administration of volatile oil LD50298mg/kg and 96mg/kg respectively; lD of ligustilide abdominal cavity injection50520 mg/kg; sodium ferulate intravenous injection and intragastric LD501.7g/kg and 3.6g/kg, respectively. The dog has intravenous injection of 2g/kg of angelica for 14 days continuously, and has no obvious effect on liver, kidney, electrocardiogram and hemogram. Feeding mice with 5% of radix Angelicae sinensis diet, and after 3-5 months, the animals grow strongly and the liver can oxidize glutamic acidThe force is significantly improved.
Ginseng, name of Chinese medicine. Is root of Panax ginseng C.A.Mey. belonging to Panax of Araliaceae. Has effects of invigorating primordial qi, invigorating spleen, benefiting lung, promoting fluid production, tranquilizing mind, and improving intelligence. It can be used for treating qi deficiency, hypolipemic, spleen qi deficiency, middle-jiao sinking, lung deficiency, asthma, cough, short breath, asthenia, thirst due to body fluid consumption, asthenia heat, diabetes, insomnia, amnesia, palpitation, blood deficiency, sallow complexion, sexual impotence, and cold womb. Sweet and slightly bitter in taste, slightly warm in nature; it enters lung, spleen and heart meridians. Chemical components: the product contains various ginsenosides, volatile oil, amino acids, trace elements, organic acids, saccharides, vitamins, etc. The pharmacological action is as follows: 1. effects on the nervous system: ginseng regulates the balance of excitatory and inhibitory processes in the central nervous system, and is manifested by small dose excitatory and large dose inhibitory effects on the central nervous system. 2. Improving brain tissue metabolism: ginseng can improve the excitation process and the inhibition process of brain, and restore the balance of the two processes. The ginsenoside Rb and Rg has protective effect on nerve tissue, and can promote the growth of nerve tissue and the establishment of nerve network. 3. Effects on memory acquisition disorders: the ginseng has bipolar and composition-dependent effects on learning and memory. 4. Effects on the pituitary-adrenal cortex system: ginseng has the effect of promoting the function of pituitary-adrenal cortex system. 5. Effects on the cardiovascular system: ginseng has the effects of exciting and inhibiting a plurality of animal hearts, exciting a small amount and inhibiting a large amount. The ginseng can increase the pressure with small dose and reduce the pressure with large dose. Ginsenoside has effects in resisting arrhythmia, protecting myocardium, reducing blood lipid, resisting arteriosclerosis, and dilating blood vessel. 6. The function of regulating the immune function: the ginsenoside can promote phagocytic function of reticuloendothelial system and increase concentration of nonspecific antibody in mouse serum. 7. Effects on the blood system: ginseng radix or its extract has effects of stimulating and protecting hematopoietic function of bone marrow, and enhancing hematopoietic function. Ginsenoside has effect in inhibiting platelet aggregation. 8. The antibacterial effect is as follows: the concentrated solution of Ginseng radix has inhibitory effect on bacteria la type shigella flexneri, beta type hemolytic streptococcus, and Penicillium purpurogenum. Higher concentration of staphylococcus aureus and Escherichia coli Anthrax bacteria, pneumococcus, Aspergillus niger, and Penicillium chrysogenum. 9. In addition, ginseng has certain functions of promoting gonadal function, promoting protein synthesis, resisting tumor, oxidation, aging, liver injury, gastric ulcer, fatigue, stress, radiation, mutation, hemostasis and the like. And (3) toxicological effects: pharmacological research shows that the ginseng and the active ingredients have low toxicity, and animal experiments can tolerate high dosage. Ginseng root powder mouse intragastric administration LD50More than 5 g/kg. Ginseng extract mouse subcutaneous injection administered LD50It was 16.5 mg/kg. Ginseng radix extract or ginsenoside for intraperitoneal injection LD50Between 300-700 mg/kg. LD of ginsenoside monomer for mouse intraperitoneal injection50Respectively as follows: rb 11110 mg/kg, Rb 2305 mg/kg, Rc410mg/kg, Rd 325mg/kg, Re 465mg/kg, Rf 1340 mg/kg, Rg 11258 mg/kg, Ro > 1000 mg/kg. LD of ginseng polypeptide for mouse intravenous injection50It was 1.62 g/kg.
Sea buckthorn, the name of traditional Chinese medicine. Is dried mature fruit of Hippophae rhamnoides L. belonging to genus Hippophae of family Elaeagnaceae. Has the effects of invigorating spleen, promoting digestion, relieving cough, eliminating phlegm, promoting blood circulation and removing blood stasis. It is mainly indicated for spleen deficiency with poor appetite, cough with excessive phlegm and blood stasis. Sweet and sour in taste and warm in nature; it enters spleen, stomach and lung meridians. Chemical components: the product contains vitamins (C, VA, VE, VB1, VB2, VB12, VK) and folic acid; flavonoids and terpenoids; proteins and various amino acids; fats and fatty acids; a saccharide. In addition, the beverage also contains alkaloid, coumarin and acidic substances, and is rich in minerals and trace elements. The pharmacological action is as follows: the fructus Hippophae flavone has effects of improving myocardial microcirculation, reducing myocardial oxygen consumption, resisting angiosclerosis, and resisting inflammation; the oleum Hippophae and its fruit juice have antifatigue, blood lipid reducing, radioprotective, antiulcer, hepatoprotective, and immunity enhancing effects.
Amomum fruit, the name of traditional Chinese medicine. Is dried mature fruit of Amomum villosum lour, Var, Xanthioides T.L.Wu et Senjen or Amomum longiligulare T.L.Wu, Amomum villosum of Amomum of Zingiberaceae. Has effects of eliminating dampness, activating qi-flowing, warming spleen and stomach, relieving diarrhea, and preventing miscarriage. It can be used for treating qi stagnation of spleen and stomach, damp obstruction of middle warmer, deficiency cold of spleen and stomach, emesis, threatened abortion, and pernicious vomiting. Pungent taste and warm nature; it enters spleen, stomach and kidney meridians. Chemical components: the YANGCHUNSHA contains volatile oil, which contains dexcamphor, borneol, bornyl acetate, limonene, nerolidol, etc., and saponin. The foundry sand contains volatile oil, which contains camphor, terpene, etc. as main components. The pharmacological action is as follows: 1. effect on gastrointestinal smooth muscle: the fructus Amomi decoction has effects in strengthening stomach, promoting secretion of digestive juice, promoting intestinal tract movement, and removing pneumatosis in digestive tube. 2. Anti-platelet aggregation: the fructus amomi can obviously inhibit platelet aggregation of the rabbit caused by ADP, has obvious protective effect on the mouse acute death induced by arachidonic acid, and has obvious effect on resisting the mouse acute death induced by collagen and adrenalin. 3. Antiulcer effect: fructus amomi can obviously reduce gastric acid secretion of rats. 4. The analgesic effect is as follows: the acetic acid writhing experiment shows that the product has obvious analgesic effect and can obviously reduce the number of mouse antibody cells.
Galangal, name of traditional Chinese medicine. Is dried rhizome of Alpinia officinarum Hance of Alpinia of Zingiberaceae. Has effects in dispelling cold, relieving pain, warming middle warmer, and relieving vomit. It is mainly used for treating stomach cold pain, stomach cold emesis. Pungent taste and hot property; it enters spleen and stomach meridians. Chemical components: contains volatile oil 0.5-1.5%, and the main components of the oil are 1, 8-cineole, methyl cinnamate, eugenol, pinene, piper cubebene and pungent galangal. Contains galangin, kaempferide, kaempferol, quercetin, isorhamnetin, etc. The pharmacological action is as follows: the water extract of the product has analgesic and anti-inflammatory effects, and the ether extract has analgesic effect, both can resist formation of animal experimental gastric ulcer and diarrhea caused by oleum ricini, and can prolong the mouth opening action duration of decapitated mice and the survival time of potassium cyanide poisoned mice; the decoction can increase the total acid output of gastric juice of dogs, excite the in vitro intestinal canal movement of rabbits, and resist the ink propulsion rate of mice after gastrointestinal inhibition caused by atropine; adopting in vivo thrombosis method, and administering rhizoma Alpiniae Officinarum water extract or volatile oil for intragastric administration to rat to achieve antithrombotic effect; the 100% decoction has effects in resisting gram-positive aerophiles such as Bacillus anthracis, alpha-or beta-hemolytic streptococcus, diphtheria and diphtheroid bacillus, pneumococcus, Staphylococcus aureus, and Staphylococcus albusAnd (4) performing bacterial action. And (3) toxicological effects: ether extract mouse gavage LD50The concentration of the soil is 0.4ml/kg, and the poisoning is characterized in that righting reflex disappears and the death lasts for more than 8 hours. The mice were drenched with 120g/kg of water extract and observed for 7 days without death. Galangal can mutate salmonella typhimurium TA98 and TA 100.
Tuckahoe, name of traditional Chinese medicine. Is dried sclerotium of Wolf of Poriacos (Schw.) of Polyporaceae family. Yun Ling is called Yun Ling in Yunnan province, and is superior in quality. Has effects of inducing diuresis to alleviate edema, eliminating dampness, invigorating spleen, and calming heart. It can be used for treating edema, phlegm retention, diarrhea due to spleen deficiency, palpitation, and insomnia. Sweet and light taste, mild in nature; it enters heart, lung and spleen meridians.
Black sesame, name of traditional Chinese medicine. Is black seed of Sesamum indicum L. of Sesamum of Pedaliaceae. Has the effects of tonifying essence and blood, moistening dryness and lubricating intestines. It can be used for treating premature gray hair, dizziness, dim eyesight, puerperal lactation deficiency, rheumatism, blood deficiency, constipation, etc. Sweet in taste and neutral in nature; it enters liver, kidney and large intestine meridians. Chemical components: the seed contains fatty oil, such as oleic acid, linoleic acid, palmitic acid, stearic acid, arachidic acid, tetracosanoic acid, glyceryl behenate, sesamin, sesamolin, sesamol, vitamin E, phytosterol, lecithin, folic acid, and further contains lipid ephedrine, protein, plantago sugar, sesamose, phosphorus, potassium, cytochrome, and calcium oxalate. The pharmacological action is as follows: 1. anti-aging effect: the black sesame seed can delay the aging phenomenon, reduce the lipofuscin level in the liver and testis, and increase the vitamin E content in the blood plasma. 2. Inhibition of adrenocortical function: the black sesame oil 0.2mg/100g can increase the content of vitamin C and cholesterol in adrenal gland, and the function of adrenal cortex is inhibited to some extent. 3. The hypoglycemic effect: semen Sesami Niger extract can reduce blood sugar, increase glycogen content and myoglycogen content, but reduce glycogen content in large dosage application. 4. The uterine stimulation effect: the water extract of semen Sesami Niger has effect in exciting uterus. 5. The anti-inflammatory effect is as follows: the fresh sterilized oleum Sesami can be applied to skin mucosa to relieve irritation and promote recovery of inflammation. 6. The function of reducing cholesterol: the linoleic acid contained in the product can reduce cholesterol content in blood. 7. In addition, the black sesame oil has the effects of increasing the blood cell volume, nourishing, relaxing bowels, inhibiting unsaturated fatty acid enzyme, and inhibiting unsaturated fatty acid enzyme by sesamin.
Preferably, the composition is mainly prepared from the following raw materials in parts by mass:
11-14 parts of cistanche, 7-10 parts of lucid ganoderma, 6-8 parts of dogwood, 7-10 parts of angelica, 4-8 parts of ginseng, 4-7 parts of sea buckthorn, 3.5-5 parts of fructus amomi, 3.5-5 parts of galangal, 11-14 parts of poria cocos and 10-14 parts of black sesame.
Preferably, the composition is mainly prepared from the following raw materials in parts by mass:
13 parts of cistanche, 8 parts of lucid ganoderma, 7 parts of dogwood, 8 parts of angelica, 6 parts of ginseng, 5 parts of sea-buckthorn, 4 parts of fructus amomi, 4 parts of galangal, 13 parts of poria cocos and 13 parts of black sesame.
A method for preparing a composition for improving energy comprises selecting radix Angelicae sinensis, Ginseng radix, fructus Hippophae, fructus Amomi, rhizoma Alpiniae Officinarum and semen Sesami Niger according to corresponding proportion, mixing, processing in a heated solvent, taking out radix Angelicae sinensis, Ginseng radix, fructus Hippophae, fructus Amomi, rhizoma Alpiniae Officinarum and semen Sesami Niger, mixing with Cistanchis herba, Ganoderma, Corni fructus and Poria, pulverizing, placing in the above processed solvent again, mixing, adding flavoring agent, and granulating to obtain the final product.
Preferably, the solvent is a vegetable oil.
Preferably, the mass ratio of the solvent to the total mass of the angelica, the ginseng, the sea buckthorn, the fructus amomi, the galangal and the black sesame is 3-6: 0.5-1.
Preferably, the heating temperature is 50-60 degrees celsius.
Preferably, the processing time is 3-4 minutes.
Preferably, the angelica, the ginseng, the sea buckthorn, the amomum villosum, the galangal and the black sesame are mixed and crushed with the cistanche, the ganoderma lucidum, the dogwood and the tuckahoe, and the grain diameter is 1200-2500 meshes;
the flavoring agent is honey;
the mass ratio of the flavoring agent to all the raw materials is 0.2-0.5: 1.
Preferably, the finished product is a pill.
The invention has the beneficial effects that:
the invention provides a composition for improving energy, which takes cistanche as a monarch drug, and has sweet, salty and warm properties; it has effects of invigorating kidney, tonifying yang, moistening intestine, and promoting fluid production; glossy ganoderma is sweet in taste and mild in nature; invigorating qi, tranquilizing mind, purifying blood, and protecting liver function; cornus officinalis is sour and astringent in taste and slightly warm in nature; enter liver and kidney meridians, tonify liver and kidney, astringe and astringe, strengthen body constitution; chinese angelica root, radix Angelicae sinensis is sweet and pungent in flavor and warm in nature; the Chinese medicinal composition has effects of tonifying blood, regulating menstruation, protecting kidney, and resisting oxidation; the ginseng is a ministerial drug which has the effects of warming the nature and entering the liver channel, tonifying the kidney and strengthening yang, enriching the blood and relieving qi; the sea-buckthorn is used for improving the immunity and resisting fatigue; fructus Amomi warms the middle-jiao and promotes qi circulation; galangal can dispel cold and relieve pain, and the whole formula is introduced; the tuckahoe and the black sesame have the effects of tonifying spleen and calming heart, tonifying essence and blood, improving strength, and simultaneously are rich in a large amount of amino acids and various vitamins and promote the absorption capacity of nutrient components.
The preparation method utilizes the temperature of the vegetable oil during short-time heating to mix with the Chinese herbal medicine raw materials, so that the effective components in the raw materials can be well fused with the oil agent, and the precipitation of the effective components and the content of the effective components in the product are improved. When all the raw materials are crushed and then are blended into the oil solution again, the use drug effect of the finished product is further ensured, no toxic or side effect is caused, and the finished product meets the condition that the content of effective components is lower than that of mouse gavage LD50And (4) standard amount.
Detailed Description
The present invention is further illustrated below with reference to specific examples. It will be appreciated by those skilled in the art that the following examples, which are set forth to illustrate the present invention, are intended to be part of the present invention, but not to be construed as limiting the scope of the present invention. The reagents used are all conventional products which are commercially available.
Example 1:
a preparation method of a composition for improving energy comprises the steps of selecting 6g of Chinese angelica, 3 g of ginseng, 3 g of sea buckthorn, 3 g of fructus amomi, 3 g of galangal and 9 g of black sesame according to a corresponding proportion, mixing the mixture in 162 g of vegetable oil heated to 50 ℃, processing for 4 minutes, fishing out the Chinese angelica, the ginseng, the sea buckthorn, the fructus amomi, the galangal and the black sesame after processing, mixing the mixture with 10g of cistanche, 6g of lucid ganoderma, 5g of dogwood and 10g of poria cocos, crushing the mixture, screening the mixture by a 1200-mesh sieve, placing the crushed mixture in the vegetable oil prepared for later use again, mixing the mixture evenly, adding 29 g of honey, and granulating to obtain a finished product.
Example 2:
a preparation method of a composition for improving energy comprises the steps of selecting 12g of Chinese angelica, 10g of ginseng, 9 g of sea buckthorn, 6g of fructus amomi, 6g of galangal and 15 g of black sesame according to a corresponding proportion, mixing the mixture in 348 g of vegetable oil heated to 60 ℃ to be processed for 3 minutes, fishing out the Chinese angelica, the ginseng, the sea buckthorn, the fructus amomi, the galangal and the black sesame after processing, mixing and crushing the mixture with 15 g of cistanche, 12g of lucid ganoderma, 10g of dogwood and 15 g of poria cocos, sieving the mixture with a 2500-mesh sieve, placing the mixture in the vegetable oil prepared for later use again, mixing the mixture evenly, adding 22 g of honey, and granulating to obtain a finished product.
Example 3:
a preparation method of a composition for improving energy comprises the steps of selecting 7g of Chinese angelica, 4g of ginseng, 4g of sea buckthorn, 3.5 g of fructus amomi, 3.5 g of galangal and 10g of black sesame according to corresponding proportions, mixing the mixture and placing the mixture in 192 g of vegetable oil heated to 50 ℃ for processing for 4 minutes, fishing out the Chinese angelica, the ginseng, the sea buckthorn, the fructus amomi, the galangal and the black sesame after the processing is finished, mixing the Chinese angelica, the ginseng, the sea buckthorn, the fructus amomi, the galangal and the black sesame with 11 g of cistanche, 7g of lucid ganoderma, 6g of dogwood and 11 g of poria cocos, crushing the mixture, screening the mixture by a 1200-mesh sieve, placing the crushed mixture in the vegetable oil for later use after the processing is finished again, mixing the mixture evenly, adding 13.5 g of honey, and granulating the mixture to obtain a finished product.
Example 4:
a preparation method of a composition for improving energy comprises the steps of selecting 10g of Chinese angelica, 8 g of ginseng, 7g of sea buckthorn, 5.5 g of fructus amomi, 5g of galangal and 14 g of black sesame according to corresponding proportions, mixing the mixture and putting the mixture into 297 g of vegetable oil heated to 60 ℃ for processing for 3 minutes, fishing out the Chinese angelica, the ginseng, the sea buckthorn, the fructus amomi, the galangal and the black sesame after processing, 14 g of cistanche, 10g of lucid ganoderma, 8 g of dogwood and 14 g of poria cocos, mixing and crushing the mixture, sieving the mixture by a 2500-mesh sieve, putting the mixture into the vegetable oil prepared for later use again, mixing the mixture evenly, adding 19.1 g of honey, and granulating to obtain a finished product
Example 5:
a preparation method of a composition for improving energy comprises the steps of selecting 8 g of Chinese angelica, 6g of ginseng, 5g of sea buckthorn, 4g of fructus amomi, 4g of galangal and 13 g of black sesame according to a corresponding proportion, mixing the mixture in 240 g of vegetable oil heated to 50 ℃, processing the mixture for 4 minutes, fishing out the Chinese angelica, the ginseng, the sea buckthorn, the fructus amomi, the galangal and the black sesame after processing, mixing the mixture with 13 g of cistanche, 8 g of lucid ganoderma, 7g of dogwood and 13 g of poria cocos, crushing the mixture, screening the mixture by a 2500-mesh screen, placing the mixture in the vegetable oil prepared for later use again, mixing the mixture evenly, adding 16.2 g of honey, and granulating to obtain a finished product.
The administration mode is as follows: the final product is honeyed pill granule, each granule is 1g, and is orally administered, wherein oral endocrine enzyme is used for gradually decomposing and absorbing components in the medicine, and daily dose is not more than 10 g.
The present invention is not limited to the above alternative embodiments, and any other products in various forms can be obtained by the present invention, and the present invention is within the protection scope of the present invention. The above embodiments should not be construed as limiting the scope of the present invention, and it will be understood by those skilled in the art that modifications may be made to the technical solutions described in the above embodiments, or equivalent substitutions may be made to some or all of the technical features thereof, without departing from the scope of the present invention, and at the same time, such modifications or substitutions may not make the essence of the corresponding technical solutions depart from the scope of the embodiments of the present invention.
Claims (10)
1. The composition for improving the energy is characterized by being prepared from the following raw materials in parts by mass:
10-15 parts of cistanche, 6-12 parts of lucid ganoderma, 5-10 parts of dogwood, 6-12 parts of angelica sinensis, 3-10 parts of ginseng, 3-9 parts of sea buckthorn, 3-6 parts of fructus amomi, 3-6 parts of galangal, 10-15 parts of poria cocos and 9-15 parts of black sesame.
2. The composition for improving energy as claimed in claim 1, wherein the composition is prepared from the following raw materials in parts by mass:
11-14 parts of cistanche, 7-10 parts of lucid ganoderma, 6-8 parts of dogwood, 7-10 parts of angelica, 4-8 parts of ginseng, 4-7 parts of sea buckthorn, 3.5-5 parts of fructus amomi, 3.5-5 parts of galangal, 11-14 parts of poria cocos and 10-14 parts of black sesame.
3. The composition for improving energy as claimed in claim 2, wherein the composition is prepared from the following raw materials in parts by mass:
13 parts of cistanche, 8 parts of lucid ganoderma, 7 parts of dogwood, 8 parts of angelica, 6 parts of ginseng, 5 parts of sea-buckthorn, 4 parts of fructus amomi, 4 parts of galangal, 13 parts of poria cocos and 13 parts of black sesame.
4. A method for preparing the composition for increasing energy according to any one of claims 1 to 3, wherein the method comprises selecting angelica sinensis, ginseng, sea buckthorn, amomum villosum, galangal and black sesame according to corresponding proportions, mixing and processing the mixture in a heated solvent, fishing out the angelica sinensis, the ginseng, the sea buckthorn, the amomum villosum, the galangal and the black sesame after processing, mixing and crushing the mixture with the cistanche, the ganoderma lucidum, the dogwood and the poria cocos, placing the mixture in the solvent prepared after processing, mixing the mixture uniformly, adding a flavoring agent, and granulating the mixture to obtain a finished product.
5. The method of claim 4, wherein the solvent is a vegetable oil.
6. The method for preparing the composition for improving energy according to claim 5, wherein the mass ratio of the solvent to the total mass of the angelica sinensis, the ginseng, the sea buckthorn, the amomum villosum, the galangal and the black sesame is 3-6: 0.5-1.
7. The method of claim 4, wherein the heating temperature is 50-60 degrees Celsius.
8. The method of claim 4, wherein the processing time is 3-4 minutes.
9. The method as claimed in claim 4, wherein the angelica, ginseng, hippophae rhamnoides, amomum villosum, galangal and black sesame are mixed with cistanche, ganoderma lucidum, dogwood and poria cocos and crushed to have a particle size of 1200-2500 meshes;
the flavoring agent is honey;
the mass ratio of the flavoring agent to all the raw materials is 0.2-0.5: 1.
10. The method of claim 4, wherein the finished product is a pill.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110910351.6A CN113456778A (en) | 2021-08-09 | 2021-08-09 | Composition for improving energy and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110910351.6A CN113456778A (en) | 2021-08-09 | 2021-08-09 | Composition for improving energy and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113456778A true CN113456778A (en) | 2021-10-01 |
Family
ID=77867714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110910351.6A Pending CN113456778A (en) | 2021-08-09 | 2021-08-09 | Composition for improving energy and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113456778A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115006506A (en) * | 2022-05-30 | 2022-09-06 | 张翔 | Ginseng preparation for nourishing and nourishing kidney and preparation method thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1081370A (en) * | 1992-07-22 | 1994-02-02 | 李高霖 | Production method of a kind of liquid that keeps healthy and products thereof |
CN101164565A (en) * | 2006-10-18 | 2008-04-23 | 武彪 | Quick-effective traditional Chinese medicine for treating beard and hair small and white, early white and alopecia in aged, and preparation method |
CN106615477A (en) * | 2017-01-22 | 2017-05-10 | 新乡市人分九种健康管理有限公司 | Compound substitutional tea with functions of warming kidney and tonifying qi, and preparation method of compound substitute tea |
CN107050182A (en) * | 2017-01-15 | 2017-08-18 | 崔悦 | The positive male balls of Bai Erxian |
CN113332390A (en) * | 2021-07-09 | 2021-09-03 | 北京贡源本草生物科技有限公司 | Traditional Chinese medicine composition for tonifying liver and kidney and preparation method thereof |
-
2021
- 2021-08-09 CN CN202110910351.6A patent/CN113456778A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1081370A (en) * | 1992-07-22 | 1994-02-02 | 李高霖 | Production method of a kind of liquid that keeps healthy and products thereof |
CN101164565A (en) * | 2006-10-18 | 2008-04-23 | 武彪 | Quick-effective traditional Chinese medicine for treating beard and hair small and white, early white and alopecia in aged, and preparation method |
CN107050182A (en) * | 2017-01-15 | 2017-08-18 | 崔悦 | The positive male balls of Bai Erxian |
CN106615477A (en) * | 2017-01-22 | 2017-05-10 | 新乡市人分九种健康管理有限公司 | Compound substitutional tea with functions of warming kidney and tonifying qi, and preparation method of compound substitute tea |
CN113332390A (en) * | 2021-07-09 | 2021-09-03 | 北京贡源本草生物科技有限公司 | Traditional Chinese medicine composition for tonifying liver and kidney and preparation method thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115006506A (en) * | 2022-05-30 | 2022-09-06 | 张翔 | Ginseng preparation for nourishing and nourishing kidney and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102048933B (en) | Chinese medicinal composition for treating infantile diarrhea and preparation method thereof | |
CN104799146A (en) | Functional nutritional good composition for improving sub-health and preparation method thereof | |
CN101612315A (en) | A kind of compound Chinese medicinal preparation that is used to adjust function of human body | |
CN105942498A (en) | Functional nutritional food compounds with diabetes-treating effects and preparation methods thereof | |
KR101855821B1 (en) | Composition for relieving of menopausal symptoms and improving blood circulation | |
CN101543248A (en) | A cold tea especially suitable for 'three high and one acid' population and method for its prepairing | |
KR102192573B1 (en) | Composition for preventing and improving menstrual pain and skin troubles | |
CN103142848B (en) | Anti-aging Chinese medicine preparation and preparation method thereof | |
CN1319403A (en) | Medicine for treating allergic purpura | |
CN113456778A (en) | Composition for improving energy and preparation method thereof | |
CN1329049C (en) | Blood sugar- and blood pressure-lowering medicine | |
KR20160000695A (en) | Herbal-medicine containing dha for recovering fatigue and enhancing memory, and method of manufacturing the same | |
CN105232987A (en) | Traditional Chinese medicine promoting neurosurgery postoperative rehabilitation | |
CN110538308B (en) | Traditional Chinese medicine composition for hair growth and preparation method thereof | |
CN111298020B (en) | Traditional Chinese medicine composition with anti-fatigue effect and preparation method and application thereof | |
CN108813500B (en) | Health-preserving honey paste with effects of tonifying middle-jiao and Qi, nourishing blood and soothing nerves and regulating human body functions | |
CN102266427A (en) | Cartialgenous and angelica wine for maintaining beauty and keeping young as well as preparation method and application thereof | |
CN105055691A (en) | Traditional Chinese medicine composition efficient in overcoming erectile dysfunction in elderly male | |
CN101669995A (en) | Composite for treatment and health care of heart cerebrovascular diseases and preparation method thereof | |
CN101828703B (en) | Product for enhancing organic immunity and improving sleeping quality and preparation method thereof | |
CN101816708B (en) | Chinese medicinal composition for curing rheumatism and preparation method thereof | |
CN107233490A (en) | A kind of maca composition of supplementing qi and nourishing yin beautifying face and moistering lotion | |
CN103110675A (en) | Soft capsule for improving alimentary anemia and preparation method thereof | |
CN108452079B (en) | Methods and compositions for delaying senescence, inhibiting tumor cell growth, and improving microcirculation | |
CN111388563B (en) | Composition for preventing breast-milk jaundice of newborn and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211001 |
|
RJ01 | Rejection of invention patent application after publication |